Nanotechnology Now

Our NanoNews Digest Sponsors

Heifer International

Wikipedia Affiliate Button

Home > Press > Phasefocus Strengthens Board with New Chairman and Directors

Abstract:
Phase Focus Ltd (Phasefocus), the company that is revolutionising microscopy and imaging with the lens-free Phasefocus Virtual Lens® technology, today announced the changes to its board of directors:

• Paul Atherton and Charles Holroyd appointed as Chairman and Non-Executive Director
• Martin Humphry appointed director and Chief Technology Officer

Phasefocus Strengthens Board with New Chairman and Directors

Sheffield, UK | Posted on November 12th, 2013

Phase Focus Ltd (Phasefocus), the company that is revolutionising microscopy and imaging with the lens-free Phasefocus Virtual Lens® technology, today announced the following changes to its board of directors:

Paul Atherton, a successful serial technology entrepreneur, has been appointed Chairman of the Board. Paul co-founded Queensgate Instruments and was Managing Director from 1988 until its sale for more than £200 million in March 2000. Paul is also Chairman of Infinitesima, NanoVentures and Nexeon, and was Chairman of C2V and Midaz Lasers until their respective acquisitions by Thermo-Fisher in 2009 and Coherent in 2012. Paul is a board member of Imperial Innovations Group plc and was involved in its £200 million AIM flotation. He earned a PhD in Physics from Imperial College and an MBA from the London Business School (of which he was a Governor for six years) and has extensive expertise in photonics, electronics, mechanics and nanotechnology.

Paul said, "I am delighted to be taking on this role. Phasefocus has already made some excellent progress and I am very much looking forward to working with the team to build on these achievements."

Charles Holroyd has also been appointed as non-executive director. For the last three years Charles has been Group Business Development Director of Oxford Instruments, a £350 million-turnover, London Stock Exchange-listed manufacturer of high technology instrumentation, with responsibility for (among other things) acquisitions, divestments and joint ventures. Previously, Charles was Managing Director of the Oxford Instruments Analytical business unit, as well as being responsible for Oxford Instruments' commercial activities and brand development in Brazil, Russia, India and China.

Martin Humphry has been appointed director and Chief Technology Officer. An inventor on a number of Phasefocus' patent applications, Martin has assumed successively higher levels of responsibility since he joined the Company in 2009, including oversight of all of its product development and R&D activities.

After five years of service with the Company, Neil Loxley will be resigning as non-executive director, due to his recent appointment as CEO of Ibex Innovations, a developer of advanced X-ray detectors.

David Baynes, CEO of Fusion IP plc and Phasefocus' outgoing Chairman, will remain a non-executive director. Commenting on the appointments, David said, "I am delighted to welcome Paul, Charles and Martin to the board. Together, these new directors will bring a wealth of technical, marketing, operational and strategic experience to our board, which will be most welcome and valuable at this important juncture in the Company's history."

Ian Pykett, CEO of Phasefocus, said, "Paul and Charles bring tremendous experience in highly relevant markets, and in growing and realising value from venture capital-backed high-technology businesses. That we have been successful in attracting their world-class skills and experiences is testament not only to the success that we have achieved to date, but also to the vision that they share with us of a potentially very bright future for Phasefocus.

"I am equally pleased that we will continue to benefit not only from Martin's considerable technical knowledge, but also from the strategic insights and business development instincts that he brings to the board.

"We will very much miss Neil, who has for four years provided expert guidance and advice gained from his extensive prior experience in the high-technology instrumentation market. We wish him well at Ibex."

To find out about the company and to learn more about using Phasefocus' unique lens-less solutions for electron microscopy, label-free live cell cycle analysis and metrology, visit www.phasefocus.com/.

####

About Phase Focus Ltd
Phasefocus is a venture capital-backed spin-out company from the University of Sheffield founded in 2006. Its principal equity investors are Ombu Group and Fusion IP plc. In February 2013, the Company announced that it had entered into a Licencing Agreement with Gatan Inc., the world's leading manufacturer of instrumentation and software used to enhance and extend the operation and performance of electron microscopes. A prototype "add-on" product for existing electron microscopes has already demonstrated an improvement in resolution of a factor of five over that available using the host instrument's conventional electron optics. Its products also include an optical microscope used for label-free time-lapse imaging of biological cells, and an Ophthalmic Lens Profiler that can measure soft contact lenses with unprecedented levels of resolution and accuracy.

For more information, please click here

Contacts:
Phase Focus Limited
Electric Works
Sheffield Digital Campus
Sheffield, S1 2BJ, UK
T +44(0)114 286 6377
M +44(0)7985 042392
http://www.phasefocus.com/


Talking Science Limited
39 de Bohun Court
Saffron Walden
Essex CB10 2BA UK
T +44(0)1799 521881
M +44(0)7843 012997
www.talking-science.com

Copyright © Phase Focus Ltd

If you have a comment, please Contact us.

Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.

Bookmark:
Delicious Digg Newsvine Google Yahoo Reddit Magnoliacom Furl Facebook

Related News Press

News and information

Metal nanoparticles induced visible-light photocatalysis: Mechanisms, applications, ways of promoting catalytic activity and outlook April 27th, 2017

Arrowhead Pharmaceuticals to Webcast Fiscal 2017 Second Quarter Results April 27th, 2017

New Product Nanoparticle preparation from Intertronics with new Thinky NP-100 Nano Pulveriser April 26th, 2017

California Research Alliance by BASF establishes more than 25 research projects in three years April 26th, 2017

Imaging

Nanoparticles open new window for biological imaging: “Quantum dots” that emit infrared light enable highly detailed images of internal body structures April 10th, 2017

The Catholic University of Rome uses the JPK NanoWizard® AFM & CellHesion® systems to understand how cells sense and respond to mechanical stimuli April 5th, 2017

Tiny sensor lays groundwork for precision X-rays detection via endoscopy:Nanoscale fiber-integrated X-ray sensor opens new doors for medical imaging and radiotherapy March 29th, 2017

“Cysteine Rose” Wins 2016 Thermo Fisher Scientific Electron Microscopy Image Contest: Thermo Fisher honors Andrea Jacassi of the Italian Institute of Technology for image of cysteine crystals using focused ion beam techniques March 27th, 2017

Announcements

Metal nanoparticles induced visible-light photocatalysis: Mechanisms, applications, ways of promoting catalytic activity and outlook April 27th, 2017

Arrowhead Pharmaceuticals to Webcast Fiscal 2017 Second Quarter Results April 27th, 2017

New Product Nanoparticle preparation from Intertronics with new Thinky NP-100 Nano Pulveriser April 26th, 2017

California Research Alliance by BASF establishes more than 25 research projects in three years April 26th, 2017

Tools

New Product Nanoparticle preparation from Intertronics with new Thinky NP-100 Nano Pulveriser April 26th, 2017

Affordable STM32 Cloud-Connectable Kit from STMicroelectronics Puts More Features On-Board for Fast and Flexible IoT-Device Development April 26th, 2017

Geoffrey Beach: Drawn to explore magnetism: Materials researcher is working on the magnetic memory of the future April 25th, 2017

NanoMONITOR shares its latest developments concerning the NanoMONITOR Software and the Monitoring stations April 21st, 2017

Appointments/Promotions/New hires/Resignations/Deaths

180 Degree Capital Corp. Announces the Start of Kevin Rendino as Chairman and Chief Executive Officer and Completion of its Transition to a Registered Closed-End Fund March 31st, 2017

Francis Alexander Named Deputy Director of Brookhaven Lab's Computational Science Initiative February 16th, 2017

Nanobiotix appoints senior executive from pharmaceutical industry, as Chief Operating Officer: Oncology industry veteran to oversee operations and product commercialization February 8th, 2017

Dr Barbara Armbruster promoted to Worldwide Sales and Marketing Director for XEI Scientific September 27th, 2016

NanoNews-Digest
The latest news from around the world, FREE



  Premium Products
NanoNews-Custom
Only the news you want to read!
 Learn More
NanoTech-Transfer
University Technology Transfer & Patents
 Learn More
NanoStrategies
Full-service, expert consulting
 Learn More











ASP
Nanotechnology Now Featured Books




NNN

The Hunger Project